Moderate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: randomised controlled trial
BMJ2011Vol. 343(jul26 2), pp. d4366–d4366
Citations Over TimeTop 1% of 2011 papers
Maartje C.J. Slagman, Femke Waanders, Marc H. Hemmelder, Arend‐Jan Woittiez, W. M. T. Janssen, Hiddo J.L. Heerspink, G. Navis, Gozewijn D. Laverman, for the HONEST (HOlland NEphrology STudy) Group
Abstract
Dietary sodium restriction to a level recommended in guidelines was more effective than dual blockade for reduction of proteinuria and blood pressure in non-diabetic nephropathy. The findings support the combined endeavours of patients and health professionals to reduce sodium intake. Trial registration Netherlands Trial Register NTR675.
Related Papers
- → Comparative Effects of Low and High Doses of the Angiotensin-Converting Enzyme Inhibitor, Lisinopril, on Morbidity and Mortality in Chronic Heart Failure(1999)1,237 cited
- → Double‐Blind Comparison of Losartan, Lisinopril, and Metolazone in Elderly Hypertensive Patients with Previous Angiotensin‐Converting Enzyme Inhibitor‐Induced Cough(1997)55 cited
- → When should ACE Inhibitors be given to normotensive patients with IDDM(1997)21 cited
- [Reversible impairment of renal function during treatment with lisinopril, an ACE-inhibitor (case report)].(2002)
- → Potential Nephrotoxicity of Lisinopril and Valsartan on Patients with Congestive Heart Failure(2017)